Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.76M.
ENTERPRISE VALUE (EV)
$1.76M
Cellyan Biotechnology Co., Ltd
Market Cap
$1.11M
Enterprise Value (EV)
$1.76M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.11M | $1.76M |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.16M | $1.39M |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | $9.72M |
| Genprex, Inc. (GNPX)vs › | $1.31M | N/A |
| Bone Biologics Corporation (BBLG)vs › | $898130.00 | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $880673.00 | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | N/A |
Market Cap
$1.11M
Total Debt
$877904.00
Cash
$221841.00
Enterprise Value
$1.76M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
